Universal Redirection of Chimeric Antigen Receptor T Cells Against Solid Tumors via Tumor Cell Membrane-Inserting CAR Ligands

Invention type: Technology / Case number: #24270H
License tlo.mit.edu/contact-us

Researchers

Angela Zhang / Laura Chen / Alexander Hostetler / Darrell Irvine

Departments: Biological Engineering, Department of Biological Engineering
Technology Areas: Biotechnology: Synthetic Biology / Therapeutics: Cell Based Therapy
Impact Areas: Healthy Living

  • car cells targeting an inserted ligand
    Patent Cooperation Treaty | Pending
  • car cells targeting an inserted ligand
    United States of America | Pending

License this technology

Interested in this technology? Connect with our experienced licensing team to initiate the process.

Contact Us

Sign up for technology updates

Sign up now to receive the latest updates on cutting-edge technologies and innovations.

Sign Up

More Technologies

Tuning Chloroplast Transgene Expression from Synthetic Operon

#25494
Christopher Voigt / Qiguo Yu
Agriculture & Food / Biotechnology / Therapeutics

A Multi-Pathway Reporter System that Interrogates Repair of DNA Double-Strand Breaks with Applications for Diagnosis and Therapeutic Treatment of Cancer and Neurodegenerative Diseases

#25444
Alex Kruswick / Michael Yaffe
Biotechnology / Diagnostics / Drug Discovery and Research Tools

An Efficient Bioconjugation Technology for Site-Selective Covalent Modification of Antibodies using an Engineered Affinity Peptide

#25358
Bradley Pentelute / Andrei Ioan Loas / Jacob Rodriguez / Heemal Dhanjee / Aurelie Rondon / Katsushi Kitahara
Biotechnology / Therapeutics